Artiva Biotherapeutics, Inc.
ARTV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$65,373 | -$28,720 | -$58,788 | -$71,825 |
| Dep. & Amort. | $2,431 | $2,266 | $1,158 | $248 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,980 | $7,053 | $6,584 | $4,307 |
| Change in WC | -$325 | -$28,280 | -$3,866 | $33,413 |
| Other Non-Cash | $1,255 | $251 | $4,083 | $18,553 |
| Operating Cash Flow | -$55,032 | -$47,430 | -$50,829 | -$15,304 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$642 | -$3,258 | -$6,299 | -$1,724 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$176,171 | -$49,517 | $0 | $0 |
| Inv. Sales/Matur. | $56,350 | $26,800 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$120,463 | -$25,975 | -$6,299 | -$1,724 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$149 | $0 | $0 | $0 |
| Stock Issued | $166,507 | $0 | $0 | $0 |
| Stock Repurch. | -$4,183 | -$12 | -$5 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $51 | $24,403 | -$1,259 | $152,754 |
| Financing Cash Flow | $162,226 | $24,391 | -$1,264 | $152,754 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$13,269 | -$49,014 | -$58,392 | $135,726 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53,762 | $102,776 | $161,168 | $25,442 |
| End Cash | $40,493 | $53,762 | $102,776 | $161,168 |
| Free Cash Flow | -$55,674 | -$50,688 | -$57,128 | -$17,028 |